Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event

BTIG to Host Obesity Health Forum


BTIG will host its first Obesity Health Forum on Wednesday, May 8, 2024. Industry-leading biotechnology firms, digital health companies with a focus on treating obesity and policymakers will be participating in the firm's virtual event which will include thematic panels and fireside chats. The forum will be hosted by:

"The development and delivery of effective obesity care has brought a shift to healthcare with broad reaching implications for every sector," said Justin Zelin, BTIG Biotechnology Analyst. "Our event will provide a forum for BTIG's institutional investor clients to explore emerging innovations, discuss latest trends and see what's on the horizon."

More than 19 public and private healthcare companies will be participating in the event. Panel discussion topics will include:

The conference is being produced by BTIG's Corporate Access program which hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate and technology sectors. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm's core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclosures/general-disclaimer/. To learn more about BTIG, visit www.btig.com.


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: